Joel Beatty
Stock Analyst at Baird
(4.2)
Main Sectors:
90 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LRMR Larimar Therapeutics | Maintains: Outperform | 10 7 | 4.87 | 43.74% | 3 | Sep 30, 2025 | |
DNTH Dianthus Therapeutic... | Maintains: Outperform | 50 67 | 34.94 | 91.76% | 3 | Sep 9, 2025 | |
EDIT Editas Medicine | Maintains: Outperform | 4 6 | 3.92 | 53.06% | 5 | Aug 13, 2025 | |
COGT Cogent Biosciences | Maintains: Neutral | 7 9 | 15.76 | -42.89% | 6 | Jul 8, 2025 | |
SAGE Sage Therapeutics | Maintains: Neutral | 7 9 | n/a | n/a | 5 | Jun 20, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 110 145 | 134.57 | 7.75% | 8 | Jun 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 31 | 21.8 | 42.2% | 4 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 38 24 | 22.34 | 7.43% | 5 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 680 680 | 800 | -15% | 7 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 29 | 15.42 | 88.07% | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 70 66 | 65.37 | 0.96% | 15 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 167 155 | 139.48 | 11.13% | 4 | May 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 162 | 120.3 | 34.66% | 5 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 38 41 | 31.06 | 32% | 3 | May 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 16 | 12.56 | 27.39% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 16 | 11.35 | 40.97% | 2 | Mar 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 117 73 | 54.38 | 34.24% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 28 32 | 20.84 | 53.55% | 2 | Mar 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 75 | 53.26 | 40.82% | 1 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 3 11 | 13.42 | -18.03% | 4 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 1.86 | 276.34% | 5 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 72 65 | 55.43 | 17.27% | 5 | Oct 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 112 127 | n/a | n/a | 3 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 60 | n/a | n/a | 2 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 72 | 31.21 | 130.7% | 4 | May 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 540 240 | 1.6 | 14900% | 3 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 | 1.35 | 233.33% | 2 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 83 103 | n/a | n/a | 2 | Apr 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | 9.38 | 166.52% | 3 | Apr 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 11 9 | 0.53 | 1598.11% | 2 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | n/a | n/a | 3 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 28 | 15.6 | 79.49% | 2 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | Sep 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 60 | n/a | n/a | 3 | Aug 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 16 | 2.08 | 669.23% | 1 | Jun 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | n/a | n/a | 1 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 2 | 1.75 | -28.57% | 2 | May 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 44 | 1.52 | 2794.74% | 3 | Apr 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 58 | 36.12 | 60.58% | 6 | Feb 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 24 | 27.64 | -13.17% | 2 | Nov 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 18 | 22.56 | -20.21% | 3 | Nov 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 6 | 2.19 | 173.97% | 2 | Aug 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 31 | n/a | n/a | 3 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 36 28 | 5.73 | 388.66% | 2 | Mar 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 170 175 | 456.35 | -61.65% | 2 | Feb 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 | 5.43 | 157.83% | 8 | Jan 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 108 | 22.64 | 377.03% | 7 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 74 | n/a | n/a | 2 | Oct 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 78 | 69.15 | 12.8% | 3 | Aug 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 440 160 | n/a | n/a | 2 | Jun 11, 2020 |